Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: Q2/2022: Sales of EUR 2.7 million and EBITDA of EUR -0.2 million below expectations in persistently challenging macroeconomic environment; growth expected for second half of 2022
DGAP-News: Q2/2022: Sales of EUR 2.7 million and EBITDA of EUR -0.2 million below expectations in persistently challenging macroeconomic environment; growth expected for second half of 2022
DGAP-News: Q2/2022: Sales of EUR 2.7 million and EBITDA of EUR -0.2 million below expectations in persistently challenging macroeconomic environment; growth expected for second half of 2022
DGAP-News: FRIEDRICH VORWERK increases order intake by 142% in the first half of the year, achieves revenues of  €143 million with an adjusted EBIT margin of 10% and adjusts profitability forecast
DGAP-News: FRIEDRICH VORWERK increases order intake by 142% in the first half of the year, achieves revenues of €143 million with an adjusted EBIT margin of 10% and adjusts profitability forecast
DGAP-News: FRIEDRICH VORWERK increases order intake by 142% in the first half of the year, achieves revenues of €143 million with an adjusted EBIT margin of 10% and adjusts profitability forecast
DGAP-News: SMT Scharf AG reports successful business performance in the first half of 2022
DGAP-News: SMT Scharf AG reports successful business performance in the first half of 2022
DGAP-News: SMT Scharf AG reports successful business performance in the first half of 2022
DGAP-News: Strong first half-year for GESCO in 2022
DGAP-News: Strong first half-year for GESCO in 2022
DGAP-News: Strong first half-year for GESCO in 2022
DGAP-News: Aumann AG: Aumann confirms growth path with €166 million order intake in the first half of 2022 and a record order backlog of €249 million
DGAP-News: Aumann AG: Aumann confirms growth path with €166 million order intake in the first half of 2022 and a record order backlog of €249 million
DGAP-News: Aumann AG: Aumann confirms growth path with €166 million order intake in the first half of 2022 and a record order backlog of €249 million
Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease
Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease
Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease
DGAP-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Achieves Strong Results in First Half of 2022 Despite Global Economic Crisis and Russia Sanctions
DGAP-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Achieves Strong Results in First Half of 2022 Despite Global Economic Crisis and Russia Sanctions
DGAP-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Achieves Strong Results in First Half of 2022 Despite Global Economic Crisis and Russia Sanctions
VZ Holding AG: VZ Group continues to grow
VZ Holding AG: VZ Group continues to grow
VZ Holding AG: VZ Group continues to grow
Silence Therapeutics Announces Pricing of Underwritten Offering
Silence Therapeutics Announces Pricing of Underwritten Offering


Silence Therapeutics plc (Nasdaq: SLN) (“Silence”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of

Cohu to Present at Upcoming Investor Conferences
Cohu to Present at Upcoming Investor Conferences


Cohu, Inc. (NASDAQ: COHU), a global leader in back-end semiconductor equipment and services, today announced that management will participate at the following investor conferences:



D.A. Davidson

State Street to Participate In Barclays Global Financial Services Conference
State Street to Participate In Barclays Global Financial Services Conference


State Street Corporation (NYSE: STT) announced today that its President & Head of Investment Services, Lou Maiuri, and its Vice Chairman & Chief Financial Officer, Eric Aboaf, will participate in

voxeljet AG Enters into Sale-Leaseback Transaction for German Facility
voxeljet AG Enters into Sale-Leaseback Transaction for German Facility


voxeljet AG (NASDAQ: VJET) (the “Company”, “voxeljet”, or “we”), a provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers, today

Gap Inc. to Report Second Quarter 2022 Results on August 25
Gap Inc. to Report Second Quarter 2022 Results on August 25


Gap Inc. (NYSE: GPS) will report its second quarter fiscal 2022 financial results by press release on August 25, 2022 at approximately 1:15 p.m. Pacific Time.



In addition, the company will host a

Savara Reports Second Quarter 2022 Financial Results and Provides Business Update
Savara Reports Second Quarter 2022 Financial Results and Provides Business Update


Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the second quarter ending June 30, 2022 and provided a

COPT Declares 99th Consecutive Common Dividend
COPT Declares 99th Consecutive Common Dividend


Corporate Office Properties Trust (NYSE: OFC) (“COPT” or the “Company”) announced today that its Board of Trustees declared a regular quarterly dividend of $0.275 per common share for the third

Hilton Grand Vacations Completes $269 Million Term Securitization
Hilton Grand Vacations Completes $269 Million Term Securitization


Hilton Grand Vacations Inc. (NYSE:HGV) announces today the completion of a $269 million securitization of Hilton Grand Vacations ownership loans through Hilton Grand Vacations Trust 2022-2 (“the

Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update


Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported financial and

Graham Corporation to Webcast Presentation and Host Investor Meetings at the Midwest IDEAS Conference
Graham Corporation to Webcast Presentation and Host Investor Meetings at the Midwest IDEAS Conference


Graham Corporation (NYSE: GHM), a global leader in the design and manufacture of mission critical fluid, power, heat transfer and vacuum technologies for the defense, space, energy and process

Kinder Morgan Acquires North American Natural Resources
Kinder Morgan Acquires North American Natural Resources


Kinder Morgan, Inc. (NYSE: KMI) today announced it has closed on the acquisition of North American Natural Resources, Inc. (NANR) and its sister companies, North American Biofuels, LLC and North

Fix Price Group PLC: Notification of PDMR transaction
Fix Price Group PLC: Notification of PDMR transaction
Fix Price Group PLC: Notification of PDMR transaction
ENOGIA signs a €6.5 million contract for the supply of ORC modules and associated services in Germany
ENOGIA signs a €6.5 million contract for the supply of ORC modules and associated services in Germany
ENOGIA signs a €6.5 million contract for the supply of ORC modules and associated services in Germany
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
ISG to Publish Report on Manufacturing Industry Services
ISG to Publish Report on Manufacturing Industry Services


Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, has launched a research study examining service and solution providers helping manufacturing

DGAP-News: Cryptology’s estimated NAV per share as of 10/08/2022 is €5.44
DGAP-News: Cryptology’s estimated NAV per share as of 10/08/2022 is €5.44
DGAP-News: Cryptology’s estimated NAV per share as of 10/08/2022 is €5.44
NORNICKEL’S SHAREHOLDERS APPROVED REDUCTION OF THE AUTHORIZED CAPITAL OF THE COMPANY
NORNICKEL’S SHAREHOLDERS APPROVED REDUCTION OF THE AUTHORIZED CAPITAL OF THE COMPANY
NORNICKEL’S SHAREHOLDERS APPROVED REDUCTION OF THE AUTHORIZED CAPITAL OF THE COMPANY